- $44.64m
- -$10.09m
- $0.86m
Annual balance sheet for Rallybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 175 | 169 | 110 | 65.5 | 54.7 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 181 | 179 | 115 | 67.8 | 61.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.511 | 0.909 | 0.592 | 0.267 | 0.198 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 182 | 180 | 116 | 68.1 | 62.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.55 | 10.7 | 9.26 | 6.24 | 4.22 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.58 | 11.1 | 9.44 | 6.45 | 4.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 176 | 169 | 106 | 61.7 | 58 |
| Total Liabilities & Shareholders' Equity | 182 | 180 | 116 | 68.1 | 62.3 |
| Total Common Shares Outstanding |